GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Aug 2013 04:30 PM
RNS
Director/PDMR Shareholding
05 Aug 2013 12:35 PM
RNS
Publication of Prospectus
02 Aug 2013 05:13 PM
RNS
Transaction in Own Shares
02 Aug 2013 03:05 PM
RNS
Regulatory Update - Albiglutide
01 Aug 2013 05:00 PM
RNS
Transaction in Own Shares
01 Aug 2013 02:13 PM
RNS
Total Voting Rights
31 Jul 2013 05:05 PM
RNS
Transaction in Own Shares
31 Jul 2013 12:41 PM
RNS
Director/PDMR Shareholding
24 Jul 2013 12:00 PM
RNS
Half Yearly Report
23 Jul 2013 04:52 PM
RNS
Transaction in Own Shares
22 Jul 2013 05:01 PM
RNS
Transaction in Own Shares
22 Jul 2013 04:11 PM
RNS
Director/PDMR Shareholding
22 Jul 2013 03:53 PM
RNS
Director/PDMR Shareholding
22 Jul 2013 11:36 AM
RNS
GSK Consumer Nigeria plc Sch of Arrangement update
19 Jul 2013 10:59 AM
RNS
Director/PDMR Shareholding
19 Jul 2013 10:57 AM
RNS
Director/PDMR Shareholding
19 Jul 2013 10:52 AM
RNS
Director/PDMR Shareholding
18 Jul 2013 12:24 PM
RNS
Director/PDMR Shareholding
17 Jul 2013 05:18 PM
RNS
Director/PDMR Shareholding
17 Jul 2013 05:16 PM
RNS
Director/PDMR Shareholding
17 Jul 2013 05:16 PM
RNS
Director/PDMR Shareholding
16 Jul 2013 02:40 PM
RNS
Director/PDMR Shareholding
16 Jul 2013 02:40 PM
RNS
Director/PDMR Shareholding
12 Jul 2013 04:46 PM
RNS
Director/PDMR Shareholding
12 Jul 2013 02:14 PM
RNS
Director/PDMR Shareholding
12 Jul 2013 02:13 PM
RNS
Director/PDMR Shareholding
11 Jul 2013 02:26 PM
RNS
Director/PDMR Shareholding
11 Jul 2013 02:21 PM
RNS
Director/PDMR Shareholding
11 Jul 2013 09:45 AM
RNS
Holding(s) in Company
10 Jul 2013 03:13 PM
RNS
Director/PDMR Shareholding
10 Jul 2013 03:12 PM
RNS
Director/PDMR Shareholding
09 Jul 2013 12:36 PM
RNS
Director/PDMR Shareholding
09 Jul 2013 12:31 PM
RNS
Director/PDMR Shareholding
09 Jul 2013 07:00 AM
RNS
US submission for BRAF/MEK combination therapy
04 Jul 2013 04:53 PM
RNS
Transaction in Own Shares
03 Jul 2013 06:04 PM
RNS
Director/PDMR Shareholding
03 Jul 2013 04:47 PM
RNS
Transaction in Own Shares
02 Jul 2013 04:44 PM
RNS
Transaction in Own Shares
01 Jul 2013 04:55 PM
RNS
Director/PDMR Shareholding
01 Jul 2013 04:55 PM
RNS
Director/PDMR Shareholding
01 Jul 2013 04:55 PM
RNS
Transaction in Own Shares
01 Jul 2013 04:53 PM
RNS
Director/PDMR Shareholding
01 Jul 2013 03:46 PM
RNS
Director/PDMR Shareholding
01 Jul 2013 11:17 AM
RNS
Total Voting Rights
28 Jun 2013 06:18 PM
RNS
Share Buy-Back Programme during close period
28 Jun 2013 05:43 PM
RNS
Transaction in Own Shares
27 Jun 2013 05:13 PM
RNS
Transaction in Own Shares
26 Jun 2013 05:27 PM
RNS
Transaction in Own Shares
25 Jun 2013 05:12 PM
RNS
Transaction in Own Shares
24 Jun 2013 05:39 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings